SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-003434
Filing Date
2022-02-15
Accepted
2022-02-15 16:35:32
Documents
35
Period of Report
2022-02-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20220215_8k.htm   iXBRL 8-K 24902
2 EXHIBIT 99.1 ex_336303.htm EX-99.1 12673
7 image01.jpg GRAPHIC 5932
8 slide01.jpg GRAPHIC 52548
9 slide02.jpg GRAPHIC 63881
10 slide03.jpg GRAPHIC 56766
11 slide04.jpg GRAPHIC 51951
12 slide05.jpg GRAPHIC 45239
13 slide06.jpg GRAPHIC 40607
14 slide07.jpg GRAPHIC 54933
15 slide08.jpg GRAPHIC 56142
16 slide09.jpg GRAPHIC 49430
17 slide10.jpg GRAPHIC 48930
18 slide11.jpg GRAPHIC 53902
19 slide12.jpg GRAPHIC 47558
20 slide13.jpg GRAPHIC 52792
21 slide14.jpg GRAPHIC 48227
22 slide15.jpg GRAPHIC 56134
23 slide16.jpg GRAPHIC 55005
24 slide17.jpg GRAPHIC 38913
25 slide18.jpg GRAPHIC 46512
26 slide19.jpg GRAPHIC 49301
27 slide20.jpg GRAPHIC 46051
  Complete submission text file 0001437749-22-003434.txt   1586170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20220215.xsd EX-101.SCH 3593
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20220215_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20220215_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20220215_pre.xml EX-101.PRE 12019
29 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20220215_8k_htm.xml XML 2650
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 22639686
SIC: 2834 Pharmaceutical Preparations